The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Open accessAbstract
Interferons (IFNs) were discovered nearly 60 years ago as a family of cytokines induced during and protecting from viral infection. They have been documented to play essential roles in numerous physiological processes beyond innate antiviral defense, including immunomodulation, regulation of the cell cycle, cell survival and differentiation, and the host response to microbial pathogens. Recent data have also uncovered a potentially darker side to the functions of IFN, including roles in autoimmunity and diabetes. Many IFN effects occur in the absence of acute viral infection, highlighting a physiologic role for constitutively produced IFN. Type I IFNs are constitutively produced at vanishingly low quantities and yet exert profound effects, mediated at least in part through modulation of signaling intermediates required for diverse cytokine response pathways. We review evidence for a yin-yang of IFN function through its role in modulating crosstalk between multiple cytokines by both feed-forward and feed-back regulation of common signaling intermediates and postulate that a similar mechanism underlies a homeostatic role for IFN through tonic signaling in the absence of acute infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Self-citationFunctional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
IFNα activates dormant haematopoietic stem cells in vivo
Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A. (2009) · Nature · doi:10.1038/nature07815 · Cited by 1,368
Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,339
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., & Ma, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80664-0 · Cited by 1,299
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Marie, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90136-1 · Cited by 1,014
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 958
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
Kirou, K. A., Lee, C., George, S., Louca, K., Peterson, M. G. E., & Crow, M. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21031 · Cited by 701
Nguyen, K. B., Salazar-Mather, T. P., Dalod, M. Y., Van Deusen, J. B., Wei, X.-Q., Liew, F. Y., Caligiuri, M. A., Durbin, J. E., & Biron, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4279 · Cited by 610
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
Musso, G., Gambino, R., & Cassader, M. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012510-175505 · Cited by 598
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Levy, D. E., Kessler, D. S., Pine, R., Reich, N., & Darnell, J. E. (1988) · Genes & Development · doi:10.1101/gad.2.4.383 · Cited by 559
Self-citationPositive feedback regulation of type I IFN genes by the IFN‐inducible transcription factor IRF‐7
Sato, M., Hata, N., Asagiri, M., Nakaya, T., Taniguchi, T., & Tanaka, N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01514-2 · Cited by 553
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., & Tough, D. F. (2002) · Blood · doi:10.1182/blood.v99.9.3263 · Cited by 534
Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice
Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H., McCoy, B., Bogdan, C., Decker, T., Brem, G., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00054-6 · Cited by 420
Sato, T., Onai, N., Yoshihara, H., Arai, F., Suda, T., & Ohteki, T. (2009) · Nature Medicine · doi:10.1038/nm.1973 · Cited by 418
Immune Response in Stat2 Knockout Mice
Park, C., Li, S., Cha, E., & Schindler, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00077-7 · Cited by 415
Hwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G., Bertoncello, I., & Kola, I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11284 · Cited by 377
Fehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J., & Caligiuri, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.219 · Cited by 373
Marrack, P., & Kappler, J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104554 · Cited by 362
Honda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934678100 · Cited by 361
Structure and Function of the Interferon- Enhanceosome
MANIATIS, T., FALVO, J. V., KIM, T. H., KIM, T. K., LIN, C. H., PAREKH, B. S., & WATHELET, M. G. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.609 · Cited by 358
Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function
Swann, J. B., Hayakawa, Y., Zerafa, N., Sheehan, K. C. F., Scott, B., Schreiber, R. D., Hertzog, P., & Smyth, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7540 · Cited by 339
Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains
Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N., & Taniguchi, T. (2000) · Science · doi:10.1126/science.288.5475.2357 · Cited by 319
Induction and function of type I and III interferon in response to viral infection
Levy, D. E., Marié, I. J., & Durbin, J. E. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.11.001 · Cited by 314
Self-citationFleetwood, A. J., Dinh, H., Cook, A. D., Hertzog, P. J., & Hamilton, J. A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1108702 · Cited by 312
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernandez-Sesma, A., Lee, C.-K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., García-Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286
Self-citationYao, Y., Richman, L., Higgs, B. W., Morehouse, C. A., de los Reyes, M., Brohawn, P., Zhang, J., White, B., Coyle, A. J., Kiener, P. A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24557 · Cited by 284
Mutational switch of an IL-6 response to an interferon-γ-like response
Costa-Pereira, A. P., Tininini, S., Strobl, B., Alonzi, T., Schlaak, J. F., Is'harc, H., Gesualdo, I., Newman, S. J., Kerr, I. M., & Poli, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122236099 · Cited by 264
Huber, J. P., & David Farrar, J. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03412.x · Cited by 258
Wong, L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., & Ralph, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28779 · Cited by 234
Sensitization of IFN-γ Jak-STAT signaling during macrophage activation
Hu, X., Herrero, C., Li, W.-P., Antoniv, T. T., Falck-Pedersen, E., Koch, A. E., Woods, J. M., Haines, G. K., & Ivashkiv, L. B. (2002) · Nature Immunology · doi:10.1038/ni828 · Cited by 231
Distinct Requirements for IFNs and STAT1 in NK Cell Function
Lee, C.-K., Rao, D. T., Gertner, R., Gimeno, R., Frey, A. B., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3571 · Cited by 217
Self-citationLizzul, P. F., Aphale, A., Malaviya, R., Sun, Y., Masud, S., Dombrovskiy, V., & Gottlieb, A. B. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23735.x · Cited by 212
Comabella, M., Lünemann, J. D., Río, J., Sánchez, A., López, C., Julià, E., Fernández, M., Nonell, L., Camiña-Tato, M., Deisenhammer, F., et al. (2009) · Brain · doi:10.1093/brain/awp228 · Cited by 206
Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., & Issazadeh-Navikas, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4776 · Cited by 200
Interferon-λs: the modulators of antivirus, antitumor, and immune responses
Li, M., Liu, X., Zhou, Y., & Su, S. B. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1208761 · Cited by 200
Deficiency of the type I interferon receptor protects mice from experimental lupus
Nacionales, D. C., Kelly‐Scumpia, K. M., Lee, P. Y., Weinstein, J. S., Lyons, R., Sobel, E., Satoh, M., & Reeves, W. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23023 · Cited by 194
Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
Gough, D. J., Messina, N. L., Hii, L., Gould, J. A., Sabapathy, K., Robertson, A. P. S., Trapani, J. A., Levy, D. E., Hertzog, P. J., Clarke, C. J. P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000361 · Cited by 193
Self-citationSTAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response
Wang, W.-B., Levy, D. E., & Lee, C.-K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004128 · Cited by 178
Self-citationMiyagi, T., Gil, M. P., Wang, X., Louten, J., Chu, W.-M., & Biron, C. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070401 · Cited by 174
Sun, W. H., Pabon, C., Alsayed, Y., Huang, P. P., Jandeska, S., Uddin, S., Platanias, L. C., & Rosen, S. T. (1998) · Blood · doi:10.1182/blood.v91.2.570 · Cited by 169
NF-κB RelA Subunit Is Crucial for Early IFN-β Expression and Resistance to RNA Virus Replication
Wang, J., Basagoudanavar, S. H., Wang, X., Hopewell, E. L., Albrecht, R. A., García‐Sastre, A., Balachandran, S., & Beg, A. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000114 · Cited by 168
Interferon-β is required for interferon-α production in mouse fibroblasts
Erlandsson, L., Blumenthal, R., Eloranta, M.-L., Engel, H., Alm, G., Weiss, S., & Leanderson, T. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70086-7 · Cited by 166
Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N., & Vogel, S. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604958200 · Cited by 153
Type I interferon in organ-targeted autoimmune and inflammatory diseases
Crow, M. K. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2886 · Cited by 138
Interferon messenger RNA is produced constitutively in the organs of normal individuals.
Tovey, M. G., Streuli, M., Gresser, I., Gugenheim, J., Blanchard, B., Guymarho, J., Vignaux, F., & Gigou, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5038 · Cited by 133
Fos and Jun Proteins Are Specifically Expressed During Differentiation of Human Keratinocytes
Mehic, D., Bakiri, L., Ghannadan, M., Wagner, E. F., & Tschachler, E. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23558.x · Cited by 131
Constitutive IFN-α/β Signal for Efficient IFN-α/β Gene Induction by Virus
Hata, N., Sato, M., Takaoka, A., Asagiri, M., Tanaka, N., & Taniguchi, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5159 · Cited by 121
Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo
Gil, M. P., Salomon, R., Louten, J., & Biron, C. A. (2005) · Blood · doi:10.1182/blood-2005-07-2834 · Cited by 110
Biologic Effects of Interferons
Gresser, I. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874776 · Cited by 109
Mitani, Y., Takaoka, A., Kim, S. H., Kato, Y. H., Yokochi, T., Tanaka, N., & Taniguchi, T. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00448.x · Cited by 108
The transcriptional code of human IFN-β gene expression
Ford, E., & Thanos, D. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.01.010 · Cited by 106
Distinct Roles for the NF-κB RelA Subunit during Antiviral Innate Immune Responses
Basagoudanavar, S. H., Thapa, R. J., Nogusa, S., Wang, J., Beg, A. A., & Balachandran, S. (2011) · Journal of Virology · doi:10.1128/jvi.02213-10 · Cited by 105
Cheng, C. S., Feldman, K. E., Lee, J., Verma, S., Huang, D.-B., Huynh, K., Chang, M., Ponomarenko, J. V., Sun, S., Benedict, C. A., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001501 · Cited by 95
Dikopoulos, N., Bertoletti, A., Kröger, A., Häuser, H., Schirmbeck, R., & Reimann, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.99 · Cited by 87
Mack, E. A., Kallal, L. E., Demers, D. A., & Biron, C. A. (2011) · mBio · doi:10.1128/mbio.00169-11 · Cited by 85
Expression of SOCS-1, Suppressor of Cytokine Signalling-1, in Human Melanoma
Li, Z., Metze, D., Nashan, D., Müller‐Tidow, C., Serve, H. L., Poremba, C., Luger, T. A., & Böhm, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23408.x · Cited by 84
Balachandran, S., & Beg, A. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002165 · Cited by 76
Gene Repression by Coactivator Repulsion
Senger, K., Merika, M., Agalioti, T., Yie, J., Escalante, C. R., Chen, G., Aggarwal, A. K., & Thanos, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00081-x · Cited by 75
Phipps‐Yonas, H., Seto, J., Sealfon, S. C., Moran, T. M., & Fernández-Sesma, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000193 · Cited by 74
Zurney, J., Howard, K. E., & Sherry, B. (2007) · Journal of Virology · doi:10.1128/jvi.01172-07 · Cited by 68
IFN-beta in rheumatoid arthritis.
Tak, P. (2004) · Frontiers in Bioscience · doi:10.2741/1475 · Cited by 67
Chen, H., Tanaka, N., Mitani, Y., Oda, E., Nozawa, H., Chen, J., Yanai, H., Negishi, H., Choi, M. K., Iwasaki, T., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01051.x · Cited by 63
Wong, L. H., Hatzinisiriou, I., Devenish, R. J., & Ralph, S. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5475 · Cited by 63
Effect of exercise on plasma interferon levels
Viti, A., Muscettola, M., Paulesu, L. R., Bocci, V. A., & Almi, A. (1985) · Journal of Applied Physiology · doi:10.1152/jappl.1985.59.2.426 · Cited by 61
Lesinski, G. B., Zimmerer, J. M., Kreiner, M., Trefry, J. C., Bill, M. A., Young, G. S., Becknell, B., & Carson, W. E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-142 · Cited by 59
Hamilton, J. A., Whitty, G. A., Kola, I., & Hertzog, P. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2553 · Cited by 58
Wong, L. H., Hatzinisiriou, I., Devenish, R. J., & Ralph, S. J. (1998) · PubMed · Cited by 58
Chronic myeloid leukemia cells resistant to interferon-α lack STAT1 expression
Landolfo, S., Guarini, A. R., Riera, L., Gariglio, M., Gribaudo, G., Cignetti, A., Cordone, I., Montefusco, E., Mandelli, F., & Foà, R. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200004 · Cited by 54
Vogel, S. N., & Fertsch, D. (1984) · Infection and Immunity · doi:10.1128/iai.45.2.417-423.1984 · Cited by 53
Interferon-β1bin multiple sclerosis
Buttmann, M., & Rieckmann, P. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.3.227 · Cited by 43
Normal human epidermis contains an interferon-like protein.
Yaar, M., Palleroni, A. V., & Gilchrest, B. A. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.103.4.1349 · Cited by 33
Weihua, X., Hu, J., Roy, S. K., Mannino, S. B., & Kalvakolanu, D. V. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00111-1 · Cited by 30
Yamazaki, M., Sato, A., Takeda, T., & Komatsu, M. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2656 · Cited by 29
van der Fits, L., van der Wel, L. I., Laman, J. D., Prens, E. P., & Verschuren, M. C. M. (2002) · The Journal of Pathology · doi:10.1002/path.1263 · Cited by 29
Arakura, F., Hida, S., Ichikawa, E., Yajima, C., Nakajima, S., Saida, T., & Taki, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3249 · Cited by 24
Interferon system defects in malignant T-cells.
Heyman, M. M., Grandér, D., Brøndum‐Nielsen, K., CEDERBLAD, B., Liu, Y., Xu, B., & Einhorn, S. (1994) · PubMed · Cited by 23
Is interferon produced in physiologic conditions?
Bocci, V. A. (1980) · Medical Hypotheses · doi:10.1016/0306-9877(80)90091-2 · Cited by 20
Cited by
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
Cai, X., Chiu, Y.-H., & Chen, Z. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.040 · Cited by 988
Antitumour actions of interferons: implications for cancer therapy
Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.14 · Cited by 907
Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection
Sarhan, J., Liu, B. C., Muendlein, H. I., Li, P., Nilson, R., Tang, A. Y., Rongvaux, A., Bunnell, S. C., Shao, F., Green, D. R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809548115 · Cited by 883
Metadata
- Authors
- Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 36
- Issue
- 2
- Pages
- 166-174
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2065794552
- Cited by
- 470
- References
- 96
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.